Philippe Moreau#


Philippe Moreau
Membership Number:7233
Membership type:ORDINARY
Section:BASIC AND CLINICAL TRANSLATIONAL SCIENCES
Elected:2025
Main Country of Residence:FRANCE
Homepage(s):





Present and Previous Positions
  • Since 2023/09 President of the International Myeloma Society (member since 2013, vice-president 2019-2013) (https://myelomasociety.org)
  • Since 2003/09 University Professor of Clinical Hematology, University of Nantes, France
  • Since 09/2003 Member of the “Integrative cancer genomics” translational research team, directed by Dr Stéphane Minvielle, INSERM, Nantes, France
  • Since 2005 Member of the International Myeloma Working Group, member of the steering committee since 2013
  • Since 1990/11 MD, Hematology department, university hospital Nantes, France
  • 2019/01 - 2023/09 Director of the ILIAD project (Imaging and Longitudinal Investigations to Ameliorate Decision making), translational and clinical research program, Nantes University, France labelled in 2018 by the French National Cancer Institute and the French Ministry of Health
  • 2021/01 - 2023/09 Head of the Hematology Nephrology Transplantation Gastroenterology Dermatology Oncology Department, university hospital Hôtel-Dieu, Nantes, France
  • 2020/01 - 2023/01 Chairman of the French cooperative group on multiple myeloma IFM Intergroupe Francophone du Myélome
  • 2017 - 2024 European Myeloma Network, member of the Board of Directors
  • 2009 - 2018 Head of the department of Hematology, university hospital Hôtel-Dieu, Nantes, France

Fields of Scholarship
  • High-dose therapy
  • Novel agents
  • Genomics of multiple myeloma
  • Multiple myeloma
  • Therapy of multiple myeloma
  • Immunotherapy

Honours and Awards
  • 2023 International, Fellow of the College of Myeloma, UK: F.C.My.(UK)
  • 2018 International, Robert Kyle life-achievement award
  • 2018 International, COMy, controversies in multiple myeloma, life-achievement award
  • 2011 National, Prize AF3M (national patient group)
  • 2000 National, Prize Paulette Ghiron-Bistagne, french society of internal medicine, AL amyloidosis

Imprint Privacy policy « This page (revision-7) was last changed on Tuesday, 3. June 2025, 11:08 by Kaiser Dana
  • operated by